Surgical infection & Antibiotic selection

Infection์˜ ์™ธ๊ณผ์  ์ •์˜

  • infection : ์™ธ๋ถ€์˜ microorganism์ด ์นจํˆฌ, ์„ธํฌ์— ์†์ƒ์„ ์ฃผ๊ฑฐ๋‚˜ ์‚ฌ๋ง์— ์ด๋ฅด๊ฒŒ ํ•˜๋Š” ๊ฒƒ
  • ์ผ๋ฐ˜์ ์œผ๋กœ 105 bacteria/1g or 1ml โ†’ ๊ฐ์—ผ์œผ๋กœ ํŒ๋‹จ.
  • ์ฆ์ƒ = cell์˜ ์†์ƒ/์‚ฌ๋ง์œผ๋กœ ์ธํ•œ ๊ฒฐ๊ณผ
  • fistula : ์žฅ๊ธฐ์™€ ์žฅ๊ธฐ ์‚ฌ์ด์˜ ๊ณ„ํ†ต์„ฑ (ํ”ผ๋ถ€, ํ”ผํ•˜, ๊ทผ์œก ํฌํ•จ)
  • ๋ฐœ์ , ๋ถ€์ข…, ํ†ต์ฆ, ์—ด๊ฐ, serous discharge

Infection(๊ฐ์—ผ) vs. Contamination(์˜ค์—ผ)

  • ์„ธ๊ท ์ด ๋งŽ์€ ๊ฒƒ์„ ๋„˜์–ด, ์„ธํฌ์— ์†์ƒ์„ ์ค˜์•ผ โ€œ๊ฐ์—ผโ€

  • ๋น„์œ„์ƒ์ ์ธ ๊ฒƒ, ์„ธ๊ท ์ด ๋งŽ์€ ๊ฒƒ์€ ์˜ค์—ผ

  • ์–ด๋–ค ํ™˜๊ฒฝ์—์„œ ๊ฐ์—ผ?

    • ๋ฏธ์ƒ๋ฌผ์˜ virulence๊ฐ€ ๊ฐ•ํ•˜๊ฑฐ๋‚˜, number ํฌ๊ฑฐ๋‚˜
    • ์ˆ˜์ˆ ์˜ local wound environment โ‡’ ๊ฐ์—ผ ๊ฐ€๋Šฅ์„ฑ์ด ๋งค์šฐ ๋†’์•„์ง (์ˆ˜์ˆ  ๋ถ€์œ„์—๋Š” blood flow X โ†’ ํ›จ์”ฌ ์ทจ์•ฝ)
    • host์˜ immunocompetence (์•„์ฃผ ์–ด๋ฆฌ๊ฑฐ๋‚˜, ๋…ธ๋ น)
  • 1์‚ด ์ดํ•˜, 10์‚ด ์ด์ƒ์˜ ๊ฐ•์•„์ง€์—์„œ๋Š” ์˜ค์—ผ์ด ๊ฐ์—ผ์œผ๋กœ ๋  ๊ฐ€๋Šฅ์„ฑ์ด ๋†’์Œ.

Surgical infection์˜ ๋ถ„๋ฅ˜

  • Primary surgical disease
    • osteromyelitis(๊ณจ์ˆ˜์—ผ, ๊ณจ์ˆ˜์— ์ด๋ฏธ ๊ฐ์—ผ), pyometra(์ž๊ถ์ถ•๋†์ฆ), peritonitis(๋ณต๋ง‰์—ผ), prostatic abscessation(์ „๋ฆฝ์„ ๋†)
  • Complication of a surgical procedure
    • ์œ„, ์žฅ, ๋ฐฉ๊ด‘, ๋‹ด๋‚ญ ๋“ฑ ์žฅ๊ธฐ๋ฅผ ์—ฌ๋Š” ์ˆ˜์ˆ ์ด ๋งŽ์Œ.
    • ์ฒ˜์น˜ ์ค‘ ์ฃผ์˜ํ•˜์ง€ ์•Š์œผ๋ฉด infection์ด ๋ฐœ์ƒํ•˜๊ธฐ ์‰ฌ์›€. ์žฅ์„ ๋งŒ์ง€๋˜ ์†์œผ๋กœ ๋ณต๊ฐ•์„ ํœ˜์ “๊ฑฐ๋‚˜..
  • Complication of a support procedures
    • ์œ ๋ฏธํ‰, ํ‰๊ฐ•์— ์œ ๋ฏธ๊ฐ€ ๊ฐ€๋“ ์ฐธ, ํ‰๊ฐ• ์ฒœ์ž
    • ๋ณต์ˆ˜ ์ฒœ์ž, ๋ผ์ธ ๋“ฑ support procedure์„ ๊ฒช์—ˆ๋˜ ํ™˜์ž โ†’ ๊ฐ์—ผ์˜ ๊ฐ€๋Šฅ์„ฑ(likelihood)์ด ๋†’์•„์ง
  • Prosthetic implants : ์ž„ํ”Œ๋ž€ํŠธ, ์‹ ์ฒด์— ์‚ฝ์ž…๋˜๋Š” ์ธ๊ณต ์žฅ์น˜

Surgical infection์˜ ์˜ˆ๋ฐฉ

์‚ฌํ›„์ฒ˜๋ฆฌ๋ณด๋‹ค ์˜ˆ๋ฐฉ์ด ์ค‘์š”.

  • Control of endogenous flora (์ฒด๋‚ด ๋ฏธ์ƒ๋ฌผ ๊ตฐ์ง‘ ์กฐ์ ˆ)
    • Patient preparation : ์ˆ˜์ˆ  ๋ถ€์œ„์˜ preparation๋งŒ ์ž˜ ํ•ด๋„ 90% ์˜ˆ๋ฐฉ!
  • Bacteria์˜ transmission์„ ์ค„์—ฌ์•ผ ํ•จ
    • Hand washing, gloves, sterilization : โ€˜์ˆ˜์ˆ ํŒ€์˜โ€™ bacteria๊ฐ€ ์˜ฎ๊ฒจ๊ฐ€์ง€ ์•Š๋„๋ก
  • Control of the hospital environment : ํ™˜๊ฒฝ์—์„œ ์˜ค์—ผ๋  ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์„ ๋ฐฉ์ง€
  • Rational antibiotic use : ํ•ฉ๋ฆฌ์ ์ธ ํ•ญ์ƒ์ œ ์‚ฌ์šฉ - ์‚ฌํ›„์ฒ˜๋ฆฌ์— ํ•ด๋‹น
  • 1~3์€ ์‹ค์Šต์—์„œ ์—ฐ์Šต, 4๋Š” ์ด๋ก ์—์„œ ๊ณต๋ถ€

Antibiotics in Small Animal Surgery

  • Prophylactic : ์˜ˆ๋ฐฉ ๋ชฉ์  (์ˆ˜์ˆ  ์ „)
  • Therapeutic : ์น˜๋ฃŒ ๋ชฉ์ 

Contamination factors

  1. Host Factors

    • ๋‚˜์ด (1์‚ด ์ดํ•˜, 10์‚ด ์ด์ƒ)
    • physical condition
    • ์˜์–‘ ์ƒํƒœ : BCS ์ฐธ๊ณ 
    • Diagnostic procedure๋ฅผ ๊ฑฐ์นœ ๊ฒฝ์šฐ : ํ‰๊ฐ• ์ฒœ์ž, ๋ณต๊ฐ• ์ฒœ์ž, ์š”๋„ ์นดํ…Œํƒ€, IV ์นดํ…Œํƒ€ ๋“ฑ
    • ๋Œ€์‚ฌ์„ฑ ์งˆํ™˜์„ ๊ฐ€์ง„ ๊ฒฝ์šฐ : ๊ฐ‘์ƒ์„ ๊ธฐ๋Šฅํ•ญ์ง„์ฆ, ๋‹น๋‡จ,
    1. History taking
      • Immunosuppressive therapy : ์ž๊ฐ€๋ฉด์—ญ์งˆํ™˜
      • previous antibiotic therapy : ๊ท“๋ณ‘ ํ•ญ์ƒ์ œ ๋“ฃ์งˆ ์•Š์Œ..
      • wound
      • body cavity drains
    2. Hospitalization period
      • ์ž…์› ๊ธฐ๊ฐ„์ด ๊ธด ๊ฒฝ์šฐ : ๋ณ‘์› ์•ˆ์˜ ๋ฏธ์ƒ๋ฌผ ๋…ธ์ถœ๋„ ๋งŽ์ด ๋˜๊ณ , ์—ฌ๋Ÿฌ ์žฅ์น˜๋ฅผ ๋‹ฌ๊ณ  ์žˆ๊ธฐ์—
  2. Wound Factor

    • ์˜ค์—ผ ๊ฐ€๋Šฅ์„ฑ ๋†’์Œ
    • hematoma, blood clot, necrotic tissue, foreign body
  3. Surgical / anesthetic duration : ์ˆ˜์ˆ  ์‹œ๊ฐ„์ด 70๋ถ„ ๋Š˜์–ด๋‚  ๋•Œ๋งˆ๋‹ค ๊ฐ์—ผ ๊ฐ€๋Šฅ์„ฑ doubling

  4. Septical anesthetic technique (propofol) : ๋ฐ”์ด์•Œ๋กœ ์“ฐ๋Š” ์•ฝ๋ฌผ. ํ•œ ๋ฒˆ์— ๋‹ค ์“ฐ๊ณ  ๋ฒ„๋ ค์•ผ ํ•˜๋Š”๋ฐ, ๋ƒ‰์žฅ๋ณด๊ด€ํ•ด์„œ ๋‚˜๋จธ์ง€ ์“ธ ๋•Œ๊ฐ€ ๋งŽ์Œ. ํ”„๋กœํฌํด์€ ํ–ฅ์ •์ด๋ผ, ๋‹จ์ˆœํžˆ ๋ฒ„๋ฆฌ๊ธฐ๋„ ๋ณต์žกํ•จ. ๋‚จ์œผ๋ฉด ๊ธฐ๋กํ•ด์„œ ๋ƒ‰์žฅ๋ณด๊ด€ํ•ด์•ผ ํ•จ. ์—ฌ๋Ÿฌ ๋ฒˆ ๋‹ˆ๋“ค์„ ๋ฝ‘์•˜๋‹ค ์“ฐ๊ฒŒ ๋˜๋Š”๋ฐ, ๋‹ˆ๋“ค์ด ์˜ค์—ผ๋˜๋ฉด IV๋กœ ์„ธ๊ท  ๋“ค์–ด๊ฐ€๋Š” ๊ฒƒ

  5. Operating room practice

    • ๊ฝ‰ ์žก์œผ๋ฉด ์ˆ˜์ˆ  ๋ถ€์œ„์— ํ—ˆํ˜ˆ์ด ์ƒ๊ฒจ ๊ฐ์—ผ ๊ฐ€๋Šฅ์„ฑ์ด ๋†’์•„์ง€๊ณ ..
    • Aseptic technique, Sterilization and disinfection, ๊ฐ€์šด, ์žฅ๊ฐ‘, ์ˆ˜์ˆ ํ™˜๊ฒฝ ์ค€๋น„, ์ˆ˜์ˆ  ํ™˜์ž, ์ˆ˜์ˆ  ๋ถ€์œ„, ์ˆ˜์ˆ ํŒ€
  6. ๊ธฐํƒ€

    • Duration
  7. Nosocomical infection

    • MRSA : ฮฒ-lactam ๊ณ„์—ด ํ•ญ์ƒ์ œ์— ์ €ํ•ญ์„ฑ (ฮฒ-lactamase๋ฅผ ๊ณ„์† ๋‚ด๋ฟœ๊ธฐ ๋•Œ๋ฌธ)
    • clebulenic acid(?)๊ฐ€ lactamase inhibitant

Antibiotics used for perioperative prophylaxis

  • ํ•ญ์ƒ์ œ๋ฅผ ์–ธ์ œ ์จ์•ผ ํ• ๊นŒ?
    • ํŠน์ • ์žฅ๊ธฐ์—์„œ ๋งŽ์ด ๋‚˜ํƒ€๋‚˜๋Š” ์„ธ๊ท ์— ๋Œ€ํ•ด -๊ฒฝํ—˜์ ์œผ๋กœ!
    • culture โ†’ ๊ฒฐ๊ณผ๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ํ•ญ์ƒ์ œ ์ฒ˜์น˜
OrganismAntibiotics
Skin incision
Gram+, cocciCefazolin (22mg/kg IV; 1์„ธ๋Œ€)- 30-60min prior to skin incision
- Repeat every 90 min
Colorectal surgery
Enteric G- (E- coli),
Anaerobe
(Bacteroides, Streptococcus)
Neomycin (20mg/kg PO, TID)1-3์ผ ์ „
Erythromycin (10-20mg/kg PO)1-3์ผ์ „
Metronidazole (20mg/kg IV)๋‹น์ผ์— 1๋ฒˆ
Gastrointestinal
G+, Enteric G-, anaerobesCefoxitin (22mg/kg IV)ํ”ผ๋ถ€ ์—ด๊ธฐ 30-60๋ถ„ ์ „
Airway
G+ (Staphylococcus),
G- (E. coli, bacilli)
Cefoxitin (22mg/kg IV)
Urogenital
E-coli (G-),
Streptococcus
Ampicillin (20mg/kg, IV)์‹œ์ž‘ํ•  ๋•Œ 1๋ฒˆ
Enrofloxacin (5mg/kg IV);
์–ด๋ฆฐ ๊ฐœ์ฒด
2์‹œ๊ฐ„๋งˆ๋‹ค
Hepatobiliary
Cefoxitin
Dentistry
Clindamycin, Clavamox,
Metronidazole, Doxycycline,
Unasyn+Chlorhexidine gel
  • ๋Œ€๋ถ€๋ถ„์˜ ์ˆ˜์ˆ ์—์„œ๋Š” ํ”ผ๋ถ€๋ฅผ ์—ด๊ฒŒ ๋˜๋ฏ€๋กœ, 30-60๋ถ„ ์ „ cefa ๊ณ„์—ด์˜ ํ•ญ์ƒ์ œ๋กœ ํ”ผ๋ถ€ ๊ฐ์—ผ์„ ์˜ˆ๋ฐฉ, ๋งค 90๋ถ„๋งˆ๋‹ค ๋ฐ˜๋ณต

  • ๋Œ€๋ถ€๋ถ„์˜ ์•ฝ์€ ์†Œ์žฅ์—์„œ ํก์ˆ˜๋จ. โ†’ colorectal ์ˆ˜์ˆ ์—๋Š” ํฐ ๋„์›€์ด ๋˜์ง€ ์•Š์Œ.

  • cefa ๊ณ„์—ด์—์„œ ์„ธ๋Œ€๊ฐ€ ์˜ฌ๋ผ๊ฐ„๋‹ค = ๊ทธ๋žŒ ์Œ์„ฑ๊ท ์— ๋” ์ž˜ ๋Œ€์‘ํ•œ๋‹ค (์–‘์„ฑ๊ท ์—๋Š” ๊ธฐ๋ณธ์ ์œผ๋กœ ์ž˜ ๋“ค์Œ)

  • Enrofloxacin

    • ๋„ˆ๋ฌด ๋นจ๋ฆฌ IV๋กœ ์ฃผ์ž…ํ•˜๋ฉด ์‡ผํฌ๊ฐ€ ์˜ฌ ์ˆ˜ ์žˆ์Œ. ํฌ์„ํ•ด์„œ ์ฒœ์ฒœํžˆ ์ฃผ์ž…ํ•˜๋Š” ๊ฒƒ์ด ์›์น™.
    • ์„ฑ์žฅ๊ธฐ ๊ฐœ์ฒด์˜ ์—ฐ๊ณจ์— ์†์ƒ์„ ์ค„ ์ˆ˜ ์žˆ์Œ. (์„ฑ์žฅํŒ ์†์ƒ ๊ฐ€๋Šฅ์„ฑ)
    • ๊ณ ์–‘์ด์—์„œ๋„ ๊ถŒ์žฅ๋˜์ง€ ์•Š์Œ

cefa 1์„ธ๋Œ€ ๊ธฐ๋ณธ + ๋‹ค๋ฅธ ์žฅ๊ธฐ๋“ค ๋ณด๊ณ  cefa์˜ ์„ธ๋Œ€๋ฅผ ์˜ฌ๋ฆฌ๊ฑฐ๋‚˜, ๋‹ค๋ฅธ ํ•ญ์ƒ์ œ๋ฅผ ์“ฐ๊ฑฐ๋‚˜ ๋“ฑ๋“ฑ

ํ•ญ์ƒ์ œํŠน์ง•
Cephalexin1์„ธ๋Œ€, ํ”ผ๋ถ€ ์ ˆ๊ฐœ ์‹œ
Cefotaxim3์„ธ๋Œ€, CSF๊นŒ์ง€
Ceftriaxone3์„ธ๋Œ€, CNS ๊นŒ์ง€
Cefovecin (Convenia)4์„ธ๋Œ€, ๊ณ ์–‘์ด pasteurella multocida ์— ์ข‹์Œ, long lasting (14์ผ)
- ๋ณดํ˜ธ์ž ์ˆ˜์š” ๋งŽ์œผ๋‚˜, ์ˆ˜์˜์‚ฌ๋Š” ์ตœํ›„์˜ ๋ณด๋ฃจ
Clavamox
(amoxicillin+clavulanic acid)
- ฮฒ-lactamase
- clavulanic acid : inhibitor
- ๊ทธ๋žŒ ์Œ์„ฑ๊ท ์— ํšจ๊ณผ์ 
Imipenem- ์ตœ๊ณ  ๊ด‘๋ฒ”์œ„ํ•จ, ์‚ฌ์šฉ ์ž์ œ. ์‹ ๋…์„ฑ ์—†์Œ.
ChloramphenicolCNS, ๋ˆˆ์— ํšจ๊ณผ ์ข‹์Œ, ๋นˆํ˜ˆ ์ฃผ์˜
Tetracyclin- calcium chelating - ์„ฑ์žฅ ๊ฐœ์ฒด/๋ชจ์œ ์ˆ˜์œ  ๊ฐœ์ฒด์—์„œ ์ฃผ์˜
ClindamycinํŽ˜๋‹ˆ์‹ค๋ฆฐ ์ €ํ•ญ๊ท ์—๋„ ํšจ๊ณผ ์ข‹์Œ
Aminoglycosides
(gentamycin,
amikacin)
- GI ํก์ˆ˜๊ฐ€ ์ž˜ ์•ˆ ๋จ,
- IV
- ์‹ ๋…์„ฑ, ์ด๋…์„ฑ
TM-Sulfa- ํ•ฉ์ œ โ†’ ๊ด‘๋ฒ”์œ„ํ•จ
complicated side effects โ†’ ์‚ฌ์šฉ ์ž์ œ
- Keratoconjunctivitis sicca (KCS, ์•ˆ๊ตฌ๊ฑด์กฐ์ฆ)
- ํ˜ˆ์†ŒํŒ๊ฐ์†Œ์ฆ
- ๋นˆํ˜ˆ
- bone marrow suppression

ํ•ญ์ƒ์ œ - ์„ธํฌ๋ฒฝ ์–ต์ œ์ œ (Cephalosporins)

Cephalosporins

  • ํŽ˜๋‹ˆ์‹ค๋ฆฐ๋ฅ˜์™€ ๋ฐ€์ ‘ํ•˜๊ฒŒ ์—ฐ๊ด€๋œ ฮฒ-lactam ํ•ญ์ƒ์ œ์ด๋‹ค.
  • ํŽ˜๋‹ˆ์‹ค๋ฆฐ๊ณผ ๋™์ผํ•œ ์ž‘์šฉ๊ธฐ์ „์„ ๊ฐ€์ง€๋ฉฐ ๊ฐ™์€ ๋‚ด์„ฑ๊ธฐ์ „์— ์˜ํ–ฅ์„ ๋ฐ›์ง€๋งŒ,
  • ์œก๊ฐํ˜• ๊ตฌ์กฐ๋กœ ์ธํ•ด ฮฒ-lactamase์— ํŽ˜๋‹ˆ์‹ค๋ฆฐ๋ณด๋‹ค ๋” ๋‚ด์„ฑ์„ ๊ฐ€์ง„๋‹ค.

ํ–ฅ๊ท ๋ฒ”์œ„

  • 1-5์„ธ๋Œ€๋กœ ๋‚˜๋‰œ๋‹ค.
    1. 1์„ธ๋Œ€ : Penicillin G์˜ ๋Œ€์ฒดํ’ˆ์ด๋‹ค.
      • cefazolin, cefadroxil, cephalexin ์ด ์žˆ๋‹ค.
      • ํฌ๋„์•Œ๊ท ์„ฑ penicillinase์— ๋Œ€ํ•œ ์ €ํ•ญ์„ ๊ฐ€์ ธ MSSA์— ํšจ๊ณผ๋ฅผ ๋ณด์ธ๋‹ค.
    2. 2์„ธ๋Œ€
      • cefotetan, cefoxitin, cefuoxime ์ด ์žˆ๋‹ค.
      • ๊ทธ๋žŒ์Œ์„ฑ๊ท ์— ๋Œ€ํ•œ ํ•ญ๊ท ๋ฒ”์œ„๊ฐ€ ์ฆ๊ฐ€ํ–ˆ๋‹ค. (์–‘์„ฑ๊ท  ํ™œ์„ฑ์€ ๊ฐ์†Œ)
      • Cephamycin๋ฅ˜( cefotetan, cefoxitin)์€ ํ˜๊ธฐ์„ฑ ๊ท ์— ํ™œ์„ฑ์„ ๊ฐ€์ง„๋‹ค. ๊ทธ๋žŒ์Œ์„ฑ ํ˜๊ธฐ์„ฑ ์„ธ๊ท ์— ์ด์šฉํ•  ์ˆ˜ ์žˆ๋Š” ์œ ์ผํ•œ cephalosporin๋ฅ˜๋‹ค.
    3. 3์„ธ๋Œ€
      • cefdinir, cefixime, ceftazidime, ceftriaxone, cefotaxime
      • MSSA์— ๋Œ€ํ•œ ํšจ๋ ฅ์€ ๋‚ฎ์ง€๋งŒ, ๊ทธ๋žŒ์Œ์„ฑ๊ฐ„๊ท ์— ๋Œ€ํ•œ ํ•ญ๊ท ํšจ๊ณผ๊ฐ€ ๋†’์•„์กŒ๋‹ค. ํ•ญ๊ท ํ™œ์„ฑ๋ฒ”์œ„์— ์žฅ๋‚ด์„ธ๊ท ์ด ํฌํ•จ๋œ๋‹ค.
    4. 4์„ธ๋Œ€
      • cefepime
      • ์—ฐ์‡„์ƒ๊ตฌ๊ท  ๋ฐ MSSA์— ๋Œ€ํ•œ ๊ด‘๋ฒ”์œ„ํ•œ ํ•ญ๊ท ์ž‘์šฉ์„ ๋ณด์ธ๋‹ค. ํ˜ธ๊ธฐ์„ฑ ๊ทธ๋žŒ์Œ์„ฑ๊ท ์—๋„ ํšจ๊ณผ๊ฐ€ ์žˆ๋‹ค.
    5. 5์„ธ๋Œ€
      • ceftaroline (3์„ธ๋Œ€ ceftriaxone ์˜ ๊ทธ๋žŒ์Œ์„ฑ๊ท ์— ๋Œ€ํ•œ ํ™œ์„ฑ๊ณผ ์œ ์‚ฌ)
      • MRSA์— ํ™œ์„ฑ์„ ๊ฐ–๋Š”, ๋ฏธ๊ตญ์—์„œ ์œ ์ผํ•˜๊ฒŒ ์ด์šฉํ•  ์ˆ˜ ์žˆ๋Š” ฮฒ-lactam์ด๋‹ค.
      • ๊ทธ๋žŒ์–‘์„ฑ๊ท ์— ๋Œ€ํ•ด ๊ด‘๋ฒ”์œ„ํ•œ ํ™œ์„ฑ์„ ๋ณด์ธ๋‹ค.

๋‚ด์„ฑ

  • ฮฒ-lactamase์— ์˜ํ•œ ฮฒ-lactam ring์˜ ๊ฐ€์ˆ˜๋ถ„ํ•ด, ๋˜๋Š” PBPs์— ๋Œ€ํ•œ ์นœํ™”์„ฑ์ด ๊ฐ์†Œํ•˜๋ฉด ๋‚ด์„ฑ์„ ๊ฐ–๋Š”๋‹ค.

์•ฝ๋™ํ•™

  • ๋ชจ๋“  cephalosporin๋ฅ˜๋Š” ๊ฒฝ๊ตฌ๋กœ์˜ ํก์ˆ˜๊ฐ€ ์ข‹์ง€ ๋ชปํ•˜๋‹ค.

๋ถ€์ž‘์šฉ

  • ํŽ˜๋‹ˆ์‹ค๋ฆฐ๋ฅ˜์™€ ์œ ์‚ฌํ•˜๋ฉฐ, ์•Œ๋ ˆ๋ฅด๊ธฐ ๋ฐ˜์‘์ด ์šฐ๋ ค๋œ๋‹ค.
Link to original

์ฐฝ์ƒ์˜ ๋ถ„๋ฅ˜

clean~contaminated : ์˜ˆ๋ฐฉ์  ์‚ฌ์šฉ (prophylactic antibiotics)

๋ถ„๋ฅ˜
Clean
(์‹ ์„ ์ฐฝ)
๋Œ€๋ถ€๋ถ„์˜ aseptic ์ฐฝ์ƒ
Nontraumatic, noninflamed
Clean-contaminated
(์‹ ์„ ์˜ค์—ผ์ฐฝ)
ํ˜ธํž™๊ธฐ, GI, ์ƒ์‹๊ธฐ ๋“ฑ ๋”๋Ÿฌ์šธ ๊ฐ€๋Šฅ์„ฑ์ด ์žˆ์œผ๋‚˜,
์ž˜ control๋˜์–ด ์•ˆ์˜ ๋‚ด์šฉ๋ฌผ์ด ๋ฐ–์œผ๋กœ ๋‚˜์˜ค์ง€ ์•Š์Œ.
Contaminated
(์˜ค์—ผ์ฐฝ)
control ์‹คํŒจ, ๋‚ด์šฉ๋ฌผ ์Ÿ์•„์ง
์‚ฌ๊ณ ๊ฐ€ ๋‚œ ์ง€ ์–ผ๋งˆ ์•ˆ๋˜์–ด, infection โ†“
Dirty
(๊ฐ์—ผ์ฐฝ)
contaminated + ์‹œ๊ฐ„์ด ์˜ค๋ž˜ ์ง€๋‚จ(old)
infection ๊ฐ€๋Šฅ์„ฑ์ด ๋งค์šฐ ๋†’์Œ
์ด๋ฏธ ์—ผ์ฆ, ๊ณ ์‹ค ์—ฌ๋Š” ์ˆ˜์ˆ (bullae osteotomy),
๋ณต๋ง‰์—ผ(peritonitis), ๋‚ด์žฅ์ฒœ๊ณต, ๋‹ด๋‚ญํŒŒ์—ด ๋“ฑ
์น˜๋ฃŒ ๋ชฉ์  ํ•ญ์ƒ์ œ ๊ณ ๋ ค

์˜ˆ๋ฐฉ์  ํ•ญ์ƒ์ œ ์ •๋ฆฌ

  • ๋งค 90๋ถ„๋งˆ๋‹ค ํ•ญ์ƒ์ œ๋ฅผ ๋ฐ˜๋ณต์ ์œผ๋กœ ํˆฌ์—ฌ

  • ์ตœ์ดˆ ํ•ญ์ƒ์ œ๋Š” ์ˆ˜์ˆ  30~60๋ถ„ ์ „์— ํˆฌ์—ฌ

  • ์ˆ˜์ˆ ์ด ๋๋‚˜์ž๋งˆ์ž ์‚ฌ์šฉ ์ค‘์ง€๊ฐ€ ์›์น™ - ์ˆ˜์ˆ  ํ›„ 24์‹œ๊ฐ„๊นŒ์ง€๋Š” ์‚ฌ์šฉํ•˜๋Š” ๊ฒƒ๋„ ํ—ˆ์šฉ

  • contaminated factor ์ค‘ host factor (๋‚˜์ด, ์งˆํ™˜, ๋ฉด์—ญ์–ต์ œ ์น˜๋ฃŒ), implant (ํ˜ˆ์•ก ๊ณต๊ธ‰์ด ์—†์–ด ๋ฏธ์ƒ๋ฌผ ์ง‘ํ•ฉ์†Œ)

  • enema, cathartic agent ์“ฐ๋ฉด X

  • familiarity๊ฐ€ ์ค‘์š”. ๋‚ด๊ฐ€ ์นœ๊ทผํ•œ ๊ฑฐ, ๋งŽ์ด ์จ๋ณธ ๊ฒŒ ์ข‹์Œ.

Considerations for Selection and Administration

  • ๊ธฐ๋ณธ์ ์œผ๋กœ๋Š” Culture ์‹œ, ํ•ญ์ƒ์ œ ์ „์— ๋ฏธ๋ฆฌ ๋”ฐ๊ณ , ๊ทธ ๋’ค์— ํ•ญ์ƒ์ œ ๊ฐ์ˆ˜์„ฑ ํ…Œ์ŠคํŠธ
  • ํ™˜์ž๊ฐ€ ์œ„ํ—˜ํ•  ๊ฒฝ์šฐ์—๋Š” ์˜ˆ์™ธ๋„ ํ—ˆ์šฉ
  • ๊ฐ€์žฅ ์ €๋ ด, toxicity ์ ๊ณ , ๊ฐ€์žฅ convenient ํ•œ ๊ฒƒ
  • ์ฆ์ƒ ํ•ด๊ฒฐ ํ›„ 2-3์ผ ํ•ญ์ƒ์ œ๋ฅผ ๋” ์“ฐ๋Š” ๊ฒƒ์ด ์ผ๋ฐ˜์ .

CASE

  • 5y, SF
  • GB rupture โ†’ Cholecystectomy
  • ์ˆ˜์ˆ  ์ „ ํ•ญ์ƒ์ œ
    • cefazolin, cofoxitin : GI, GB ์ชฝ์—๋Š” ๊ทธ๋žŒ ์Œ์„ฑ๊ท ์ด ํ”ผ๋ถ€ ์ชฝ๋ณด๋‹ค ๋งŽ์œผ๋‹ˆ, 2์„ธ๋Œ€ cefa ๊ณ„์—ด์ด ๋” ์ข‹๋‹ค (+ํ”ผ๋ถ€ ์ชฝ์—์„œ ์˜ค๋Š” ์–‘์„ฑ๊ท ๊นŒ์ง€)
    • ๋ณดํ†ต culture ๋”ธ ๋•Œ๋Š” flushing์„ ๋งŽ์ด ํ•จ. โ† ์‹ฌ๋ถ€์— ์žˆ๋Š”, ๋ฌธ์ œ ๋  ๋งŒํ•œ ๊ท ์„ ์žก๊ธฐ ์œ„ํ•ด. flushing๋งŒ ์ž˜ ํ•ด๋„ ์„ธ๊ท ์˜ 90% ์ด์ƒ์€ ์ œ๊ฑฐ๋˜๋ฏ€๋กœ. ์‹ฌ๋ถ€์— ์žˆ๋Š” ๊ฑธ ์ž˜ ์žก์•„์•ผ ํ•จ.
  • ์„ธ๊ท  ๋ฐฐ์–‘ ๊ฒฐ๊ณผ No Growth๊ฐ€ ๋‚˜์˜ด.
  • ์น˜๋ฃŒ ๋ชฉ์ ์œผ๋กœ cefazolin, cefoxitin

* ํƒ์ƒ‰์  ๊ฐœ๋ณต๋ฒ• ์ฑ•ํ„ฐ : ๋…น๊ฐ•